Works matching IS 03407004 AND DT 2013 AND VI 62 AND IP 2

Results: 17

T cell profiling reveals high CD4CTLA-4 T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 245, doi. 10.1007/s00262-012-1330-5

By:

Santegoets, Saskia;
Stam, Anita;
Lougheed, Sinéad;
Gall, Helen;
Scholten, Petra;
Reijm, Martine;
Jooss, Karin;
Sacks, Natalie;
Hege, Kristen;
Lowy, Israel;
Cuillerot, Jean-Marie;
Blomberg, B.;
Scheper, Rik;
den Eertwegh, Alfons;
Gerritsen, Winald;
Gruijl, Tanja

Publication type:

Article

CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 347, doi. 10.1007/s00262-012-1331-4

By:

Naito, Masayasu;
Hainz, Ursula;
Burkhardt, Ute;
Fu, Buyin;
Ahove, Deborah;
Stevenson, Kristen;
Rajasagi, Mohini;
Zhu, Baogong;
Alonso, Anselmo;
Witten, Elizabeth;
Matsuoka, Ken-ichi;
Neuberg, Donna;
Duke-Cohan, Jonathan;
Wu, Catherine;
Freeman, Gordon

Publication type:

Article

Proposed mechanism of off-target toxicity for antibody-drug conjugates driven by mannose receptor uptake.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 217, doi. 10.1007/s00262-012-1369-3

By:

Gorovits, Boris;
Krinos-Fiorotti, Corinna

Publication type:

Article

Identification of a novel HLA-A2-restricted mutated Survivin epitope and induction of specific anti-HCC CTLs that could effectively cross-recognize wild-type Survivin antigen.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 393, doi. 10.1007/s00262-012-1323-4

By:

Shen, Han;
Shao, Hong-Wei;
Chen, Xiao-Hua;
Wu, Feng-Lin;
Wang, Hui;
Huang, Zhao-Liang;
Shen, Juan;
Wang, Teng;
Zhang, Wen-Feng;
Huang, Shu-Lin

Publication type:

Article

Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 321, doi. 10.1007/s00262-012-1342-1

By:

Knights, Ashley;
Fucikova, Jitka;
Pasam, Anupama;
Koernig, Sandra;
Cebon, Jonathan

Publication type:

Article

The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 371, doi. 10.1007/s00262-012-1338-x

By:

Aldrich, Joel;
Shearer, Michael;
Lowe, Devin;
Winn, Richard;
Jumper, Cynthia;
Kennedy, Ronald;
Bright, Robert

Publication type:

Article

Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 285, doi. 10.1007/s00262-012-1334-1

By:

Hobo, Willemijn;
Novobrantseva, Tatiana;
Fredrix, Hanny;
Wong, Jamie;
Milstein, Stuart;
Epstein-Barash, Hila;
Liu, Ju;
Schaap, Nicolaas;
Voort, Robbert;
Dolstra, Harry

Publication type:

Article

Chemoimmunotherapy: reengineering tumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 203, doi. 10.1007/s00262-012-1388-0

By:

Chen, Gang;
Emens, Leisha

Publication type:

Article

Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 383, doi. 10.1007/s00262-012-1343-0

By:

Tongu, Miki;
Harashima, Nanae;
Monma, Hiroyuki;
Inao, Touko;
Yamada, Takaya;
Kawauchi, Hideyuki;
Harada, Mamoru

Publication type:

Article

Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 309, doi. 10.1007/s00262-012-1341-2

By:

Hattar, Katja;
Savai, Rajkumar;
Subtil, Florentine;
Wilhelm, Jochen;
Schmall, Anja;
Lang, Dagmar;
Goldmann, Torsten;
Eul, Bastian;
Dahlem, Gabriele;
Fink, Ludger;
Schermuly, Ralph-Theo;
Banat, Gamal-Andre;
Sibelius, Ulf;
Grimminger, Friedrich;
Vollmer, Ekkehard;
Seeger, Werner;
Grandel, Ulrich

Publication type:

Article

Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 225, doi. 10.1007/s00262-012-1324-3

By:

Bunt, Stephanie;
Mohr, Ashley;
Bailey, Jennifer;
Grandgenett, Paul;
Hollingsworth, Michael

Publication type:

Article

MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 359, doi. 10.1007/s00262-012-1336-z

By:

Soto, Carolina;
Stone, Jennifer;
Chervin, Adam;
Engels, Boris;
Schreiber, Hans;
Roy, Edward;
Kranz, David

Publication type:

Article

DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 337, doi. 10.1007/s00262-012-1340-3

By:

Tekpli, Xavier;
Landvik, Nina;
Anmarkud, Kristine;
Skaug, Vidar;
Haugen, Aage;
Zienolddiny, Shanbeh

Publication type:

Article

Tumor-specific CD4 T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 257, doi. 10.1007/s00262-012-1329-y

By:

Akhmetzyanova, Ilseyar;
Zelinskyy, Gennadiy;
Schimmer, Simone;
Brandau, Sven;
Altenhoff, Petra;
Sparwasser, Tim;
Dittmer, Ulf

Publication type:

Article

The antitumor effect of the Toll-like receptor 3 ligand polyinosinic-cytidylic acid as an adjuvant.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 237, doi. 10.1007/s00262-012-1328-z

By:

Huang, Yu-Kun;
Zheng, Zhi;
Cheng, Chun-Xia;
Wang, Lu-Ying;
Li, Yue-Ran;
Qiu, Fu

Publication type:

Article

CD40 pathway activation reveals dual function for macrophages in human endometrial cancer cell survival and invasion.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 273, doi. 10.1007/s00262-012-1333-2

By:

Dumas, Geneviève;
Dufresne, Mathieu;
Asselin, Éric;
Girouard, Julie;
Carrier, Christian;
Reyes-Moreno, Carlos

Publication type:

Article

Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 2, p. 299, doi. 10.1007/s00262-012-1332-3

By:

Duffy, Austin;
Zhao, Fei;
Haile, Lydia;
Gamrekelashvili, Jaba;
Fioravanti, Suzanne;
Ma, Chi;
Kapanadze, Tamar;
Compton, Kathryn;
Figg, William;
Greten, Tim

Publication type:

Article